Development of Glycoanalytical Methods for Characterization of Biosimilar Monoclonal Antibodies
暂无分享,去创建一个
[1] Pauline M Rudd,et al. A novel broad specificity fucosidase capable of core α1-6 fucose release from N-glycans labeled with urea-linked fluorescent dyes , 2018, Scientific Reports.
[2] Johanna E. Camara,et al. Expression and characterization of 15N-labeled human C-reactive protein in Escherichia coli and Pichia pastoris for use in isotope-dilution mass spectrometry. , 2012, Protein expression and purification.
[3] John E. Schiel,et al. Qualification of NISTmAb charge heterogeneity control assays , 2018, Analytical and Bioanalytical Chemistry.
[4] John E. Schiel,et al. Development of orthogonal NISTmAb size heterogeneity control methods , 2018, Analytical and Bioanalytical Chemistry.
[5] H. Beck,et al. Therapeutic monoclonal antibody N-glycosylation - Structure, function and therapeutic potential. , 2017, Biologicals : journal of the International Association of Biological Standardization.
[6] Huawei Qiu,et al. The Mechanistic Impact of N-Glycosylation on Stability, Pharmacokinetics, and Immunogenicity of Therapeutic Proteins. , 2019, Journal of pharmaceutical sciences.
[7] T. Creighton. Methods in Enzymology , 1968, The Yale Journal of Biology and Medicine.
[8] R. Dougherty. Mass spectrometry principles and applications , 1997 .
[9] Kurt Brorson,et al. Determination of the NISTmAb Primary Structure , 2015 .
[10] Chen Chen,et al. Challenges of glycosylation analysis and control: an integrated approach to producing optimal and consistent therapeutic drugs. , 2016, Drug discovery today.
[11] G. Wiederschain,et al. Essentials of glycobiology , 2009, Biochemistry (Moscow).
[12] R. Aebersold,et al. Mass spectrometry-based proteomics , 2003, Nature.
[13] John E. Schiel,et al. The NISTmAb Reference Material 8671 lifecycle management and quality plan , 2018, Analytical and Bioanalytical Chemistry.
[14] Y. Yu,et al. Rapid Preparation of Released N-Glycans for HILIC Analysis Using a Labeling Reagent that Facilitates Sensitive Fluorescence and ESI-MS Detection. , 2015, Analytical chemistry.
[15] J. Reichert,et al. Development trends for human monoclonal antibody therapeutics , 2010, Nature Reviews Drug Discovery.
[16] R. Caprioli,et al. Peptides and proteins , 2001, Nature.
[17] John E. Schiel,et al. The NISTmAb Reference Material 8671 value assignment, homogeneity, and stability , 2018, Analytical and Bioanalytical Chemistry.
[18] John E. Schiel,et al. Bioreactor process parameter screening utilizing a Plackett-Burman design for a model monoclonal antibody. , 2015, Journal of pharmaceutical sciences.
[19] Pauline M. Rudd,et al. Glycan characterization of the NIST RM monoclonal antibody using a total analytical solution: From sample preparation to data analysis , 2017, mAbs.
[20] John E. Schiel. Glycoprotein analysis using mass spectrometry: unraveling the layers of complexity , 2012, Analytical and Bioanalytical Chemistry.
[21] J. Lakbub,et al. State‐of‐the‐art technologies for rapid and high‐throughput sample preparation and analysis of N‐glycans from antibodies , 2016, Electrophoresis.